F. Boufassa et al., INFLUENCE OF NEUROLOGIC MANIFESTATIONS OF PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION ON DISEASE PROGRESSION, The Journal of infectious diseases, 171(5), 1995, pp. 1190-1195
To determine the influence of neurologic manifestations of primary hum
an immunodeficiency virus (HIV) infection on disease progression, 277
nonhemophiliac adults enrolled <1 year after HIV infection were studie
d, Patients with neurologic manifestations during symptomatic primary
HIV infection (PSI) (group N+; n = 23), with nonneurologic manifestati
ons (group N-; n = 112) during PSI, and without any clinical manifesta
tion during primary infection (group NPI; n = 142) were compared for d
isease progression, Age at infection, sex, mode of infection and CD4() cell count at first visit did not differ between groups, In a Cox mo
del, the relative risk (RR) of developing AIDS was 6.11 (95% confidenc
e interval [CI], 1.94-19.28) in group Nf and 2.32 (95% CI, 0.93-5.83)
in group N- compared with group NPI, The RR of AIDS onset after adjust
ment for treatment and age at infection was, respectively, 4.65 (95% C
I, 1.43-15.03) and 2.03 (95% CI, 0.80-5.19) in groups N+ and N-, Neuro
logic manifestations of primary HIV infection are associated with an a
ccelerated progression of disease.